A cost model shows anti-VEGF savings only when high injection burden offsets device fees and reading time in AI home OCT vs clinic OCT.
Carl Rosenthal, BSc
Advertisement
Articles by Carl Rosenthal, BSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently
2
Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains
3
Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM
4
Health Care Is Fixable: Workers’ Compensation Shows Employers Don’t Need to Wait for Washington
5